This difference in the number of MYCN‐amplified retinoblastomas carrying two, one, or zero RB1 mutations (eight, four, and six, respectively) compared to MYCN‐low tumors (195, 25, and seven, respectively) was significant (P < 0.001, Table 1). Here, MYCN is linked to retinoblastoma.